Play
Video

Current Studies

Clinical trials advance medical treatment and therapy to increase survival and quality of life.  

Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.  

Successful treatments we know today are the result of past clinical trials. 

Purpose

The purpose of ARTEMIDE-Lung03 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st Line treatment in participants with non-squamous metastatic Non-Small Cell Lung Cancer & whose tumors express PD-L1 (TC ≥ 1%).

For more information please visit https://clinicaltrials.gov/study/NCT06627647

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .